The significance of the oxidative stress markers in the one-year prognosis of patients with acute ischemic stroke: a case-control study

Table 2 Comparison of baseline characteristics between Healthy control, Stroke and diabetes groups

Variables	Group 1	Group 2	Mean difference	P-value*
Age	Healthy control	Stroke group	1.55	0.72
Age	Healthy control	Stoke risk group	1.42	0.80
BMI	Healthy control	Stroke group	−0.36	0.94
BMI	Healthy control	Stoke risk group	−0.47	0.92
DBP	Healthy control	Stroke group	−7.55	0.00
DBP	Healthy control	Stoke risk group	−14.27	0.00
SBP	Healthy control	Stroke group	−18.71	0.00
SBP	Healthy control	Stoke risk group	−27.70	0.00
Total cholesterol	Healthy control	Stroke group	−32.88	0.00
Total cholesterol	Healthy control	Stoke risk group	−9.51	0.69
Triglyceride	Healthy control	Stroke group	−55.94	0.00
Triglyceride	Healthy control	Stoke risk group	−29.24	0.13
LDL	Healthy control	Stroke group	−20.99	0.13
LDL	Healthy control	Stoke risk group	−13.22	0.48
HDL	Healthy control	Stroke group	−3.91	0.34
HDL	Healthy control	Stoke risk group	−1.17	0.91
Serum TAC	Healthy control	Stroke group	218.62	0.46
Serum TAC	Healthy control	Stoke risk group	−3.31	1.00
Serum MDA	Healthy control	Stroke group	−0.23	0.00
Serum MDA	Healthy control	Stoke risk group	0.10	0.35

Abbreviations: BMI Body mass index, DBP Diastolic blood pressure, SBP Systolic blood pressure, LDL Low-density lipoprotein, HDL High-density lipoprotein, TAC Total antioxidant capacity, MDA Malondialdehyde
*P-values calculated using one-way ANOVA test

ISSN: 1471-2377